PL3416622T3 - Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych - Google Patents

Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych

Info

Publication number
PL3416622T3
PL3416622T3 PL17753695.0T PL17753695T PL3416622T3 PL 3416622 T3 PL3416622 T3 PL 3416622T3 PL 17753695 T PL17753695 T PL 17753695T PL 3416622 T3 PL3416622 T3 PL 3416622T3
Authority
PL
Poland
Prior art keywords
positively charged
charged liposomes
lipophilic molecule
molecule carriers
carriers
Prior art date
Application number
PL17753695.0T
Other languages
English (en)
Inventor
Diogo DE SOUSA MARTINS
Original Assignee
Kemin Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries, Inc. filed Critical Kemin Industries, Inc.
Publication of PL3416622T3 publication Critical patent/PL3416622T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL17753695.0T 2016-02-15 2017-02-14 Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych PL3416622T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662295253P 2016-02-15 2016-02-15
PCT/US2017/017763 WO2017142854A1 (en) 2016-02-15 2017-02-14 Positively charged liposomes as lipophilic molecule carriers

Publications (1)

Publication Number Publication Date
PL3416622T3 true PL3416622T3 (pl) 2023-09-11

Family

ID=59560170

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17753695.0T PL3416622T3 (pl) 2016-02-15 2017-02-14 Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych

Country Status (7)

Country Link
US (1) US10201508B2 (pl)
EP (1) EP3416622B1 (pl)
ES (1) ES2949696T3 (pl)
PL (1) PL3416622T3 (pl)
PT (1) PT3416622T (pl)
RU (1) RU2718065C2 (pl)
WO (1) WO2017142854A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022192275A1 (en) * 2021-03-08 2022-09-15 University Of Connecticut Assisted loading of hydrophobic molecules into liposomes

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186183A (en) * 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US7109361B2 (en) * 2003-03-07 2006-09-19 Nu-Tein Co., Inc. Isolation of lutein from alfalfa
EP1750671B1 (en) * 2004-06-03 2008-10-15 Bracco Research S.A. Liposomal assembly for therapeutic and/or diagnostic use
PL1768657T3 (pl) * 2004-06-23 2009-01-30 Revision Therapeutics Inc Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20100034749A1 (en) * 2006-07-10 2010-02-11 Medigene Ag Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
US20100093648A1 (en) * 2008-10-09 2010-04-15 Antonio Cruz Treatment of macular degeneration-related disorders
WO2011041377A1 (en) * 2009-09-29 2011-04-07 Eyegate Pharmaceuticals, Inc. Ocular iontophoresis of charged micelles containing bioactive agents
US20110052678A1 (en) * 2010-11-05 2011-03-03 Shantha Totada R Method for treating age related macular degeneration
RU2516893C1 (ru) * 2012-12-14 2014-05-20 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий" Липосомальная композиция и способ ее получения
US9622970B2 (en) * 2014-05-08 2017-04-18 Yaguang Liu Pharmaceutical composition containing lutein and antioxidant for treating and preventing human disease
US10327946B2 (en) 2014-12-19 2019-06-25 Kemin Industries, Inc. Intraocular delivery of bioactive molecules using iontophoresis

Also Published As

Publication number Publication date
PT3416622T (pt) 2023-08-28
RU2718065C2 (ru) 2020-03-30
EP3416622A1 (en) 2018-12-26
RU2018132740A3 (pl) 2020-03-17
ES2949696T3 (es) 2023-10-02
EP3416622A4 (en) 2019-10-09
BR112018016471A2 (pt) 2018-12-26
US20170231920A1 (en) 2017-08-17
EP3416622B1 (en) 2023-06-28
WO2017142854A1 (en) 2017-08-24
US10201508B2 (en) 2019-02-12
RU2018132740A (ru) 2020-03-17

Similar Documents

Publication Publication Date Title
IL253170A0 (en) Benzapine dicarboxamide compounds
IL252009A0 (en) Immunoregulatory factors
IL252010A0 (en) Immunoregulatory factors
EP3284084A4 (en) Deep neural support vector machines
ZA201700824B (en) Carrier molecule for antigens
GB201614100D0 (en) Carriers
IL243285A0 (en) Analogues of lipids and liposomes containing them
GB201502252D0 (en) Carrier
HUE044663T2 (hu) Feljavított motorszerkezet
PL3515757T3 (pl) Zoptymalizowana pod względem ścieżki obciążenia hybrydowa struktura nośna
EP3207036A4 (en) Novel small molecule anticancer agents
EP2828953A4 (en) ISOLATOR INTERPHASE
PT3144626T (pt) Estrutura de transporte pirotécnico
GB201607925D0 (en) Support poles
PL3140140T3 (pl) Wspornik osadzenia koła
PL3416622T3 (pl) Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych
IL248370B (en) Covalently modified peptides with lipid extensions as neuroprotective components
GB201603522D0 (en) Pyrazolochalcones as potential anticancer agents
ZA201704290B (en) Benzazepine dicarboxamide compounds
GB201610710D0 (en) PBC compounds
AP00932S1 (en) Pole supports
AU363935S (en) Bag carrier
GB201510013D0 (en) PBC compounds
AU2016248V (en) Starburst Tulbaghia hybrid
GB201603064D0 (en) Peg cover